Press Releases

Direct-to-Consumer Laboratory Testing Market at A CAGR of 25.9% from 2022 to 2030

Share This Article

Conducting Several Types of Test with User Convenience Rapidly Attracting New Consumers

The direct-to-consumer (DTC) laboratory testing is an efficient way for consumers to order tests directly from a laboratory without having to work with their healthcare providers. The healthcare industry is shifting their focus from being physician-focused to being consumer-focused. Thus, the DTC lab testing is one of the manifestations of the healthcare sector dreamed in the mid-1900s. An increasing number of patients are moving toward the idea of getting tested without having to go through a lengthy in-clinic process, which is fueling the global direct-to-consumer laboratory testing market. The test results are used to identify previously unknown medical disorders by monitoring an existing health condition. It also helps to access data about personal health aspects. The advancement in DTC lab testing is very essential to increase patient’s and individual’s engagement in monitoring their healthcare. Thus, it is crucial for laboratory professionals to upgrade their equipment timely to provide precise test results with full understanding.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111522

Presently, many laboratories that offer DTC laboratory testing provide basic tests such as chemistry panels, complete blood count (CBC), pregnancy test, diabetes screening, and blood typing. According to healthcare guidelines in some nations, screening tests can be allowed to facilitate the early detection of diseases. The test helps people to monitor disease and obtain treatment accordingly. Additionally, the tests come provided with descriptions of benefits, risks, and conditions that are also easily understood. The tests offered by DTC laboratories are often waived tests to ensure a low risk of receiving incorrect results. The development in DTC testing has enabled consumers to buy OTC test kits to collect the sample and mail it to a laboratory that performs the test. Growing consumer convenience and rise in awareness among consumers are driving the demand for the global direct-to-consumer laboratory testing market during the forecast period.

DTC Tests Prove Crucial in Critical Response Plan to Fight against COVID-19

The global market in the year 2020 experienced a vast slowdown in almost every industry, owing to the COVID-19 pandemic. Major businesses were asked to postpone or shut their projects in order to contain the spread of coronavirus. Lockdowns, restraint in the supply chain, limited industrial work, and restrictions on the global import-export were implemented by several governments, which hampered industrial growth across the world. However, DTC testing continues to be the backbone in the fight against the coronavirus disease, maintaining containment efforts to decrease the outbreak. The severity of this pandemic and expanding capacity issues linked with the polymerase chain reaction (PCR)-based testing expedited the development of diagnostic solutions to fulfill the demand for mass testing. Various tests of in-vitro diagnostics, including molecular and immunological tests, were the primary focus of DTC testing innovations, which kept the direct-to-consumer laboratory testing market moving through the pandemic in spite of limited resources to perform the tests.

View full report@ https://qyresearchmedical.com/report/direct-to-consumer-laboratory-testing-market-sample-type-blood-urine-saliva-and-others-test-type-genetic-testing-disease-risk-assessment-testing-cbc-diabetes-testing-tsh-testing-and-others-and-end-user-2021-2031/111522

The direct-to-consumer laboratory testing market witnessed an increasing demand for rapid and easy-to-use tests to promote testing outside of laboratory settings. This resulted in the development of immunological tests to detect the presence of viral surface antigens utilizing an antibody. The COVID-19 pandemic caused by the severe acute respiratory syndrome CoV-2 presented an unusual global challenge that reshaped the exercises across the DTC testing innovation landscape. However, the direct-to-consumer laboratory testing market has witnessed a growth in demand amidst the pandemic and is further expected to expand with several people becoming familiar with the process. Furthermore, the growing prevalence of infectious diseases is one of the major factors driving market demand in the post COVID-19. The COVID-19 outbreak similar to other highly contagious infections has led to the rapid development and adoption of DTC testing as part of the critical response plan, propelling the direct-to-consumer laboratory testing market.

Growing Consumer Preference to Perform Tests with Confidentiality Boosts Market Growth

The DTC testing is an interesting extension to the traditional healthcare model for customers desiring information of their health situation and disease risk, ancestry, and their body’s expected response to certain prescriptions based on their genotype. The advantages of DTC testing are enticing and driving the direct-to-consumer laboratory testing market. The traditional model of laboratory testing in healthcare begins with the patient identifying the need to see a doctor. Waiting for test results and interpretative data from their doctor can be a source of stress. Reasonably, consumers are ready for a new healthcare model with increased convenience and detailed diagnostic reports without having to go through lengthy procedures. Moreover, the direct-to-consumer laboratory testing menu is ever-expanding, and DTC tests are promoted for a variety of uses. Typical sample types are cheek swabs, saliva or spit, urine, hair, blood spots, or blood. Moreover, there are thousands of DTC tests presently available with more being developed. One common test is DTC genetic tests, which use a saliva sample and is analyzed by genotyping.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111522/2900

The difficulty of scheduling and waiting for an appointment with physician conflicts with consumers’ lifestyles. In-office wait times can be long and are negatively associated with patient satisfaction and the likelihood to recommend a physician. On the contrary, DTC companies allow testing without an appointment. Many businesses also offer telehealth benefits for consumers to discuss lab results with a medical professional. Additionally, another appeal of DTC lab tests is confidentiality. Results cannot be shared with anyone unless patients share the result themselves. People may feel more comfortable attempting out testing options for sexually transmitted infections, screening for drugs of abuse, reproduction, and fertility-related tests when the results will be confidential. All these factors are most likely to fuel the demand for the global direct-to-consumer laboratory testing market during the projected timeline.

North America to Lead Direct-to-Consumer Laboratory Testing Market

The rising prevalence of lifestyle-associated and contagious diseases in North America is likely to drive the direct-to-consumer laboratory testing market during the forecast period. Furthermore, increasing consumer awareness and enhancing lifestyles in Europe are expected to boost the direct-to-consumer laboratory testing market in the region.  In addition, the increase in government initiatives to promote enhanced, user-friendly diagnostics and genetic research in countries across Asia is expected to fuel the growth of the direct-to-consumer laboratory testing market.

The global direct-to-consumer laboratory testing market is projected to expand at a CAGR of 25.9% from 2021 to 2031.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Direct-to-Consumer Laboratory Testing Market

Analysts’ Viewpoint

The modern world demand increased convenience in the everyday aspect of life, including lifecare. With technology becoming smart and people becoming smarter, several consumers seek more control over their health and are willing to pay for DTC service to save time and effort. However, consumers must weigh the recognized benefits with potential risks, including privacy affairs, due to the possibility of gaining confusing health information, or information that could generate unexpected emotions, misdiagnosis, and over-testing. In some regions, retail outlets are also including onsite testing for glucose and cholesterol as well as tests that are later sent out to reference laboratories. The growing spread of DTC tests across developing and developed regions is anticipated to drive the direct-to-consumer laboratory testing market during the forecast period.

Direct-to-Consumer Laboratory Testing Market: Overview

This report analyzes the current scenario and future prospects of the global direct-to-consumer laboratory testing market. Surge in demand for early disease detection & diagnosis coupled with personalized medicines, rise in prevalence of various lifestyle associated and infectious diseases, and increase in geriatric population are key factors that are projected to propel the global market during the forecast period.

The report includes an elaborate executive summary, which provides a snapshot of various segments of the global direct-to-consumer laboratory testing market. It also provides information and data analysis of the direct-to-consumer laboratory testing market about segments based on sample type, test type, end user, and region.

The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global direct-to-consumer laboratory testing market

The report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the global direct-to-consumer laboratory testing market

The report on the direct-to-consumer laboratory testing market offers market attractiveness analysis of regions and segments

The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global direct-to-consumer laboratory testing market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global direct-to-consumer laboratory testing market.

Direct-to-Consumer Laboratory Testing Market: Key Segments

In terms of sample type, the global direct-to-consumer laboratory testing market has been classified into blood, urine, saliva, and others. The saliva segment is projected to account for a major share of the market. The segment’s dominance can be attributed to increase in the number of DTC testing companies offering saliva-based test kits.

Based on test type, the global direct-to-consumer laboratory testing market has been categorized into genetic testing, disease risk assessment testing, CBC, diabetes testing, TSH testing, and others. The disease risk assessment testing segment has been further split into cancer, STDs, and others. The genetic testing segment dominated the market in 2020. Number of users of DTC test kits for ancestry and health & fitness has increased at a rapid pace. The number of people interested in knowing about their ancestors and family tree has increased, which is also anticipated to increase the demand for DNA test kits, especially in developed countries across the globe.

In terms of end user, the global direct-to-consumer laboratory testing market has been classified into hospitals, clinics, specialty labs, and diagnostic centers. The diagnostic centers segment is projected to account for a major share of the market. Rise in the number of public–private partnerships is expected to drive the segment during the forecast period.

Market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segments has also been provided from 2021 to 2031, considering 2020 as the base year.

Direct-to-Consumer Laboratory Testing Market: Regional Outlook

In terms of region, the global direct-to-consumer laboratory testing market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, Switzerland, Russia and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.

The direct-to-consumer laboratory testing market report provides size and forecast for each region and country/sub-region from 2017 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The direct-to-consumer laboratory testing market study also covers the competitive scenario in these regions.

Companies Covered in Direct-to-Consumer Laboratory Testing Market Report

Key players in the global direct-to-consumer laboratory testing market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies

Major companies profiled in the direct-to-consumer laboratory testing market report are

Laboratory Corporation of America Holdings

  • Quest Diagnostics Incorporated
  • 23andMe, Inc.
  • EverlyWell, Inc.
  • DirectLabs, LLC
  • Ancestry
  • MyMedLab, Inc.
  • WellnessFX
  • ANY LAB TEST NOW
  • LetsGetChecked
  • Color Genomics

Key Questions Answered in Direct-to-Consumer Laboratory Testing Market Report

  • What is the revenue forecast for the global direct-to-consumer laboratory testing market in terms of revenue for the period 2021–2031?
  • How would various dynamics such as drivers, restraints, opportunities, and trends impact the market?
  • What is the market size and estimation for the direct-to-consumer laboratory testing market across regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa?
  • Which regional market is poised to expand at a significant CAGR during the forecast period?
  • Which product segment is projected to generate considerable revenue in 2031 and which application segment will register the fastest CAGR during the forecast period?

Direct-to-Consumer Laboratory Testing Market – Segmentation

Sample Type

  • Blood
  • Urine
  • Saliva
  • Others

Test Type

  • Genetic Testing
  • Disease Risk Assessment Testing
  • Cancer
  • STDs
  • Others

CBC

  • Diabetes Testing
  • TSH Testing
  • Others

End User

  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Direct-to-Consumer Laboratory Testing Market

4. Market Overview

4.1. Introduction

4.1.1. Product Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031

4.4.1. Market Revenue Projections (US$ Mn)

4.4.2. Market Volume/Unit Shipments Projections

4.5. Porter’s Five Force Analysis

5. Key Insights

5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)

5.2. Disease Prevalence & Incidence Rate

5.3. Regulatory Scenario

5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

6.3.1. Genetic testing

6.3.2. Disease risk assessment testing

6.3.2.1. Cancer

6.3.2.2. STDs

6.3.2.3. Others

6.3.3. CBC

6.3.4. Diabetes testing

6.3.5. TSH testing

6.3.6. Others

6.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Test Type

7. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type , 2017–2031

7.3.1. Blood

7.3.2. Urine

7.3.3. Saliva

7.3.4. Others

7.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Sample Type

8. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by End-user

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

8.3.1. Hospitals

8.3.2. Clinics

8.3.3. Specialty labs

8.3.4. Diagnostic centres

8.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by End-user

9. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Country/Region

10. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

10.2.1. Genetic testing

10.2.2. Disease risk assessment testing

10.2.2.1. Cancer

10.2.2.2. STDs

10.2.2.3. Others

10.2.3. CBC

10.2.4. Diabetes testing

10.2.5. TSH testing

10.2.6. Others

10.3. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031

10.3.1. Blood

10.3.2. Urine

10.3.3. Saliva

10.3.4. Others

10.4. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

10.4.1. Hospitals

10.4.2. Clinics

10.4.3. Specialty labs

10.4.4. Diagnostic centres

10.5. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country, 2017–2031

10.5.1. U.S.

10.5.2. Canada

10.6. North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

10.6.1. By Test Type

10.6.2. By Sample Type

10.6.3. By End-user

10.6.4. By Country

11. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

11.2.1. Genetic testing

11.2.2. Disease risk assessment testing

11.2.2.1. Cancer

11.2.2.2. STDs

11.2.2.3. Others

11.2.3. CBC

11.2.4. Diabetes testing

11.2.5. TSH testing

11.2.6. Others

11.3. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031

11.3.1. Blood

11.3.2. Urine

11.3.3. Saliva

11.3.4. Others

11.4. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

11.4.1. Hospitals

11.4.2. Clinics

11.4.3. Specialty labs

11.4.4. Diagnostic centres

11.5. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

11.6.1. By Test Type

11.6.2. By Sample Type

11.6.3. By End-user

11.6.4. By Country/Sub-region

12. Asia Pacific Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

12.2.1. Genetic testing

12.2.2. Disease risk assessment testing

12.2.2.1. Cancer

12.2.2.2. STDs

12.2.2.3. Others

12.2.3. CBC

12.2.4. Diabetes testing

12.2.5. TSH testing

12.2.6. Others

12.3. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031

12.3.1. Blood

12.3.2. Urine

12.3.3. Saliva

12.3.4. Others

12.4. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

12.4.1. Hospitals

12.4.2. Clinics

12.4.3. Specialty labs

12.4.4. Diagnostic centres

12.5. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

12.6.1. By Test Type

12.6.2. By Sample Type

12.6.3. By End-user

12.6.4. By Country/Sub-region

13. Latin America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

13.2.1. Genetic testing

13.2.2. Disease risk assessment testing

13.2.2.1. Cancer

13.2.2.2. STDs

13.2.2.3. Others

13.2.3. CBC

13.2.4. Diabetes testing

13.2.5. TSH testing

13.2.6. Others

13.3. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031

13.3.1. Blood

13.3.2. Urine

13.3.3. Saliva

13.3.4. Others

13.4. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

13.4.1. Hospitals

13.4.2. Clinics

13.4.3. Specialty labs

13.4.4. Diagnostic centres

13.5. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Market Attractiveness Analysis

13.6.1. By Test Type

13.6.2. By Sample Type

13.6.3. By End-user

13.6.4. By Country/Sub-region

14. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031

14.2.1. Genetic testing

14.2.2. Disease risk assessment testing

14.2.2.1. Cancer

14.2.2.2. STDs

14.2.2.3. Others

14.2.3. CBC

14.2.4. Diabetes testing

14.2.5. TSH testing

14.2.6. Others

14.3. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031

14.3.1. Blood

14.3.2. Urine

14.3.3. Saliva

14.3.4. Others

14.4. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031

14.4.1. Hospitals

14.4.2. Clinics

14.4.3. Specialty labs

14.4.4. Diagnostic centers

14.5. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis

14.6.1. By Test Type

14.6.2. By Sample Type

14.6.3. By End-user

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Company Profiles

15.1.1. Laboratory Corporation of America Holdings

15.1.1.1. Company Overview

15.1.1.2. Company Financials

15.1.1.3. Growth Strategies

15.1.1.4. SWOT Analysis

15.1.2. Quest Diagnostics Incorporated

15.1.2.1. Company Overview

15.1.2.2. Company Financials

15.1.2.3. Growth Strategies

15.1.2.4. SWOT Analysis

15.1.3. 23andMe, Inc.

15.1.3.1. Company Overview

15.1.3.2. Company Financials

15.1.3.3. Growth Strategies

15.1.3.4. SWOT Analysis

15.1.4. EverlyWell, Inc

15.1.4.1. Company Overview

15.1.4.2. Company Financials

15.1.4.3. Growth Strategies

15.1.4.4. SWOT Analysis

15.1.5. DirectLabs, LLC

15.1.5.1. Company Overview

15.1.5.2. Company Financials

15.1.5.3. Growth Strategies

15.1.5.4. SWOT Analysis

15.1.6. Ancestry

15.1.6.1. Company Overview

15.1.6.2. Company Financials

15.1.6.3. Growth Strategies

15.1.6.4. SWOT Analysis

15.1.7. MyMedLab, Inc.

15.1.7.1. Company Overview

15.1.7.2. Company Financials

15.1.7.3. Growth Strategies

15.1.7.4. SWOT Analysis

15.1.8. WellnessFX

15.1.8.1. Company Overview

15.1.8.2. Company Financials

15.1.8.3. Growth Strategies

15.1.8.4. SWOT Analysis

15.1.9. ANY LAB TEST NOW

15.1.9.1. Company Overview

15.1.9.2. Company Financials

15.1.9.3. Growth Strategies

15.1.9.4. SWOT Analysis

15.1.10. LetsGetChecked

15.1.10.1. Company Overview

15.1.10.2. Company Financials

15.1.10.3. Growth Strategies

15.1.10.4. SWOT Analysis

15.1.11. Color Genomics

15.1.11.1. Company Overview

15.1.11.2. Company Financials

15.1.11.3. Growth Strategies

15.1.11.4. SWOT Analysis

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111522/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Related Articles

Back to top button